Viewing StudyNCT05209152



Ignite Creation Date: 2024-05-06 @ 5:08 PM
Last Modification Date: 2024-10-26 @ 2:23 PM
Study NCT ID: NCT05209152
Status: COMPLETED
Last Update Posted: 2024-04-30
First Post: 2022-01-13

Brief Title: AMG 176 With Azacitidine in Subjects With Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia
Sponsor: Amgen
Organization: Amgen

Conditions & Keywords Data

Conditions:
Name
Chronic Myelomonocytic Leukemia
Higher Risk Myelodysplastic Syndrome
Keywords:
Name View
Myelomonocytic Leukemia View
Higher Risk Myelodysplastic Syndrome View
Chronic Myelomonocytic Leukemia View
Myelodysplastic Syndrome View